PES-HORISONT-EU-PES Horisont Europa
The Rapid commercialization of an AlgiNate therapy for reSPIRatory diseasEs - TRANSPIRE
AlgiPharma has developed a novel low molecular weight alginate OligoG™ from seaweed that restores normal mucus function and makes chronic infections more susceptible to antimicrobial therapy. Airway mucus is a key protective barrier: OligoG™ facilitates the secretion and flow of airway mucus, pre...